Enalapril vs Upadacitinib
Enalapril vs Upadacitinib: Overview
This comparison examines the pharmacological differences between Enalapril and Upadacitinib.
Mechanism of Action
Enalapril: Prodrug converted to enalaprilat; inhibits ACE preventing angiotensin I to II conversion.
Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.
Pharmacokinetics
Half-life: Enalapril β 11 hours; Upadacitinib β 9-14 hours.
Chemical Properties
Molecular Formula: Enalapril β C20H28N2O5; Upadacitinib β C17H19F3N6O.
Molecular Weight: Enalapril β 376.4470 g/mol; Upadacitinib β 380.3700 g/mol.
Type: Enalapril β Small molecule; Upadacitinib β Small molecule.